3,5-di-tert-butyl-4-hydroxybenzoic acid has been researched along with propylparaben in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Mizutani, T; Tajima, K; Takemura, M; Yamamoto, K | 1 |
Beckers, HH; Comuth, PA; Henderson, PT; Kleinjans, JC; Maas, LM; ten Hoor, F; Verhagen, H | 1 |
Cokic, P; Moon, JY; Park, C; Webster, DA | 1 |
Auguet, M; Chabrier, PE; Cornet, S; Spinnewyn, B | 1 |
Athanasekou, C; Rekka, EA; Theodosis-Nobelos, P | 1 |
Kourounakis, A; Lambrinidis, G; Tzara, A | 1 |
6 other study(ies) available for 3,5-di-tert-butyl-4-hydroxybenzoic acid and propylparaben
Article | Year |
---|---|
Further metabolism of 3,5-di-tert-butyl-4-hydroxybenzoic acid, a major metabolite of butylated hydroxytoluene, in rats.
Topics: Animals; Biotransformation; Butylated Hydroxytoluene; Male; Parabens; Rats; Rats, Inbred Strains | 1991 |
Disposition of single oral doses of butylated hydroxytoluene in man and rat.
Topics: Administration, Oral; Adult; Animals; Biotransformation; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Drug Interactions; Feces; Female; Humans; Male; Parabens; Rats; Rats, Inbred Strains | 1989 |
Na(+)-translocating cytochrome bo terminal oxidase from Vitreoscilla: some parameters of its Na+ pumping and orientation in synthetic vesicles.
Topics: Ascorbic Acid; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cytochrome b Group; Cytochromes; Electron Transport Complex IV; Escherichia coli Proteins; Gram-Negative Bacteria; Ionophores; Kinetics; Liposomes; Oxygen; Parabens; Permeability; Phenylenediamines; Phospholipids; Sodium; Sodium-Potassium-Exchanging ATPase; Substrate Specificity; Ubiquinone | 1996 |
Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia.
Topics: Animals; Antioxidants; Cerebral Infarction; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitric Oxide Synthase; Nitroarginine; Parabens; Rats; Rats, Sprague-Dawley | 1999 |
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Antioxidants; Butanes; Carrageenan; Chemical and Drug Induced Liver Injury; Cysteine; Edema; Free Radicals; Hyperlipidemias; Lipid Peroxidation; Oxidative Stress; Parabens; Protective Agents; Rats | 2017 |
Design of Multifaceted Antioxidants: Shifting towards Anti-Inflammatory and Antihyperlipidemic Activity.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Chromans; Drug Design; Humans; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Lipoxygenase; Lipoxygenase Inhibitors; Molecular Docking Simulation; Nerve Degeneration; Oxidative Stress; Parabens; Structure-Activity Relationship | 2021 |